Top

Reviews in Endocrine and Metabolic Disorders

Published in:

01-03-2015

The update of anthocyanins on obesity and type 2 diabetes: Experimental evidence and clinical perspectives

Authors: Honghui Guo, Wenhua Ling

Published in: Reviews in Endocrine and Metabolic Disorders | Issue 1/2015

Abstract

With the dramatically increasing prevalence of obesity and type 2 diabetes mellitus (T2DM) worldwide, there is an urgent need for new strategies to combat the growing epidemic of these metabolic diseases. Diet is an essential factor affecting the development of and risk for obesity and T2DM and it can either help or hurt. In searching for preventative and therapeutic strategies, it is therefore advantageous to consider the potential of certain foods and their bioactive compounds to reverse or prevent the pathogenic processes associated with metabolic disease. Anthocyanins are naturally occurring polyphenolic compounds abundant in dark-colored fruits, vegetables and grains. Epidemiological studies suggest that increased consumption of anthocyanins lowers the risk of T2DM. Many in vitro and in vivo studies also reveal an array of mechanisms through which anthocyanins could prevent or reverse obesity- and T2DM-related pathologies including promotion of antioxidant and anti-inflammatory activities, improvement of insulin resistance, and hypolipidemic and hypoglycemic actions. Here, we summarize the data on anthocyanin-mediated protection against obesity and T2DM and the underlying mechanisms. Further population-based and long-term human intervention studies are necessary to ultimately evaluate the use of anthocyanins for protection/prevention against the development of obesity and T2DM.

Ma RC, Chan JC. Type 2 diabetes in east Asians: Similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci. 2013;1281:64–91. doi:10.1111/nyas.12098.CrossRefPubMedCentralPubMed

Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008;359(20):2105–20. doi:10.1056/NEJMoa0801891.CrossRefPubMed

Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath Jr CW. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341(15):1097–105. doi:10.1056/NEJM199910073411501.CrossRefPubMed

Andersen CJ, Fernandez ML. Dietary strategies to reduce metabolic syndrome. Rev Endocr Metab Disord. 2013;14(3):241–54. doi:10.1007/s11154-013-9251-y.CrossRefPubMed

He K, Hu FB, Colditz GA, Manson JE, Willett WC, Liu S. Changes in intake of fruits and vegetables in relation to risk of obesity and weight gain among middle-aged women. Int J Obes Relat Metab Disord. 2004;28(12):1569–74. doi:10.1038/sj.ijo.0802795.CrossRefPubMed

Slavin JL, Lloyd B. Health benefits of fruits and vegetables. Adv Nutr. 2012;3(4):506–16. doi:10.3945/an.112.002154.CrossRefPubMedCentralPubMed

Munir KM, Chandrasekaran S, Gao F, Quon MJ. Mechanisms for food polyphenols to ameliorate insulin resistance and endothelial dysfunction: Therapeutic implications for diabetes and its cardiovascular complications. Am J Physiol Endocrinol Metab. 2013;305(6):E679–86. doi:10.1152/ajpendo.00377.2013.CrossRefPubMedCentralPubMed

Timmers S, Hesselink MK, Schrauwen P. Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits? Ann N Y Acad Sci. 2013;1290:83–9. doi:10.1111/nyas.12185.CrossRefPubMed

He J, Giusti MM. Anthocyanins: natural colorants with health-promoting properties. Annu Rev Food Sci Technol. 2010;1:163–87. doi:10.1146/annurev.food.080708.100754.CrossRefPubMed

10.

Williams CA, Grayer RJ. Anthocyanins and other flavonoids. Nat Prod Rep. 2004;21(4):539–73. doi:10.1039/B311404J.CrossRefPubMed

11.

Sd P-T, Sanchez-Ballesta MT. Anthocyanins: From plant to health. Phytochem Rev. 2008;7(2):281–99. doi:10.1007/s11101-007-9074-0.CrossRef

12.

Prior RL, Wu X. Anthocyanins: Structural characteristics that result in unique metabolic patterns and biological activities. Free Radic Res. 2006;40(10):1014–28. doi:10.1080/10715760600758522.CrossRefPubMed

13.

Wu X, Beecher GR, Holden JM, Haytowitz DB, Gebhardt SE, Prior RL. Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J Agric Food Chem. 2006;54(11):4069–75. doi:10.1021/jf060300l.CrossRefPubMed

14.

Koponen JM, Happonen AM, Mattila PH, Torronen AR. Contents of anthocyanins and ellagitannins in selected foods consumed in Finland. J Agric Food Chem. 2007;55(4):1612–9. doi:10.1021/jf062897a.CrossRefPubMed

15.

Bindon K, Varela C, Kennedy J, Holt H, Herderich M. Relationships between harvest time and wine composition in Vitis vinifera L. cv. Cabernet Sauvignon 1. Grape and wine chemistry. Food Chem. 2013;138(2–3):1696–705. doi:10.1016/j.foodchem.2012.09.146.CrossRefPubMed

16.

Perez-Jimenez J, Neveu V, Vos F, Scalbert A. Systematic analysis of the content of 502 polyphenols in 452 foods and beverages: An application of the phenol-explorer database. J Agric Food Chem. 2010;58(8):4959–69. doi:10.1021/jf100128b.CrossRefPubMed

17.

Bhagwat S, Haytowitz DB, Wasswa-Kintu SI, Holden JM. USDA develops a database for flavonoids to assess dietary intakes. Procedia Food Science. 2013;2:81–6. doi:10.1016/j.profoo.2013.04.013.CrossRef

18.

Kuhnau J. The flavonoids. A class of semi-essential food components: Their role in human nutrition. World Rev Nutr Diet. 1976;24:117–91.PubMed

19.

Zamora-Ros R, Knaze V, Lujan-Barroso L, Slimani N, Romieu I, Touillaud M, et al. Estimation of the intake of anthocyanidins and their food sources in the European prospective investigation into cancer and nutrition (EPIC) study. Br J Nutr. 2011;106(7):1090–9. doi:10.1017/S0007114511001437.CrossRefPubMed

20.

Li G, Zhu Y, Zhang Y, Lang J, Chen Y, Ling W. Estimated daily flavonoid and stilbene intake from fruits, vegetables, and nuts and associations with lipid profiles in Chinese adults. J Acad Nutr Diet. 2013;113(6):786–94. doi:10.1016/j.jand.2013.01.018.CrossRefPubMed

21.

Lako J, Wattanapenpaiboon N, Wahlqvist M, Trenerry C. Phytochemical intakes of the Fijian population. Asia Pac J Clin Nutr. 2006;15(2):275–85.PubMed

22.

Drossard C, Bolzenius K, Kunz C, Kersting M. Anthocyanins in the diet of children and adolescents: intake, sources and trends. Eur J Nutr. 2013;52(2):667–76. doi:10.1007/s00394-012-0371-z.CrossRefPubMed

23.

Drossard C, Alexy U, Bolzenius K, Kunz C, Kersting M. Anthocyanins in the diet of infants and toddlers: Intake, sources and trends. Eur J Nutr. 2011;50(8):705–11. doi:10.1007/s00394-011-0184-5.CrossRefPubMed

24.

Johannot L, Somerset SM. Age-related variations in flavonoid intake and sources in the Australian population. Public Health Nutr. 2006;9(8):1045–54.CrossRefPubMed

25.

Perez-Jimenez J, Fezeu L, Touvier M, Arnault N, Manach C, Hercberg S, et al. Dietary intake of 337 polyphenols in French adults. Am J Clin Nutr. 2011;93(6):1220–8. doi:10.3945/ajcn.110.007096.CrossRefPubMed

26.

Ovaskainen ML, Torronen R, Koponen JM, Sinkko H, Hellstrom J, Reinivuo H, et al. Dietary intake and major food sources of polyphenols in Finnish adults. J Nutr. 2008;138(3):562–6.PubMed

27.

Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, et al. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr. 2002;76(3):560–8.PubMed

28.

Mursu J, Virtanen JK, Tuomainen TP, Nurmi T, Voutilainen S. Intake of fruit, berries, and vegetables and risk of type 2 diabetes in Finnish men: The Kuopio ischaemic heart disease risk factor study. Am J Clin Nutr. 2014;99(2):328–33. doi:10.3945/ajcn.113.069641.CrossRefPubMed

29.

Muraki I, Imamura F, Manson JE, Hu FB, Willett WC, van Dam RM, et al. Fruit consumption and risk of type 2 diabetes: Results from three prospective longitudinal cohort studies. BMJ. 2013;347:f5001. doi:10.1136/bmj.f5001.CrossRefPubMedCentralPubMed

30.

Cassidy A, O’Reilly EJ, Kay C, Sampson L, Franz M, Forman JP, et al. Habitual intake of flavonoid subclasses and incident hypertension in adults. Am J Clin Nutr. 2011;93(2):338–47. doi:10.3945/ajcn.110.006783.CrossRefPubMedCentralPubMed

31.

Wedick NM, Pan A, Cassidy A, Rimm EB, Sampson L, Rosner B, et al. Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. Am J Clin Nutr. 2012;95(4):925–33.CrossRefPubMedCentralPubMed

32.

Jacques PF, Cassidy A, Rogers G, Peterson JJ, Meigs JB, Dwyer JT. Higher dietary flavonol intake is associated with lower incidence of type 2 diabetes. J Nutr. 2013;143(9):1474–80. doi:10.3945/jn.113.177212.CrossRefPubMedCentralPubMed

33.

Jennings A, Welch AA, Fairweather-Tait SJ, Kay C, Minihane AM, Chowienczyk P, et al. Higher anthocyanin intake is associated with lower arterial stiffness and central blood pressure in women. Am J Clin Nutr. 2012;96(4):781–8. doi:10.3945/ajcn.112.042036.CrossRefPubMed

34.

Jennings A, Welch AA, Spector T, Macgregor A, Cassidy A. Intakes of anthocyanins and flavones are associated with biomarkers of insulin resistance and inflammation in women. J Nutr. 2014;144(2):202–8. doi:10.3945/jn.113.184358.CrossRefPubMed

35.

Wang C, Yatsuya H, Tamakoshi K, Uemura M, Li Y, Wada K, et al. Positive association between high-sensitivity C-reactive protein and incidence of type 2 diabetes mellitus in Japanese workers: 6-year follow-up. Diabetes Metab Res Rev. 2013;29(5):398–405. doi:10.1002/dmrr.2406.CrossRefPubMed

36.

Stull AJ, Cash KC, Johnson WD, Champagne CM, Cefalu WT. Bioactives in blueberries improve insulin sensitivity in obese, insulin-resistant men and women. J Nutr. 2010;140(10):1764–8. doi:10.3945/jn.110.125336.CrossRefPubMedCentralPubMed

37.

Qin Y, Xia M, Ma J, Hao Y, Liu J, Mou H, et al. Anthocyanin supplementation improves serum LDL- and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects. Am J Clin Nutr. 2009;90(3):485–92.CrossRefPubMed

38.

Zhu Y, Xia M, Yang Y, Liu F, Li Z, Hao Y, et al. Purified anthocyanin supplementation improves endothelial function via NO-cGMP activation in hypercholesterolemic individuals. Clin Chem. 2011;57(11):1524–33. doi:10.1373/clinchem.2011.167361.CrossRefPubMed

39.

Zhu Y, Huang X, Zhang Y, Wang Y, Liu Y, Sun R, et al. Anthocyanin supplementation improves HDL-associated paraoxonase 1 activity and enhances cholesterol efflux capacity in subjects with hypercholesterolemia. J Clin Endocrinol Metab. 2014;99(2):561–9. doi:10.1210/jc.2013-2845.CrossRefPubMed

40.

Zhu Y, Ling W, Guo H, Song F, Ye Q, Zou T, et al. Anti-inflammatory effect of purified dietary anthocyanin in adults with hypercholesterolemia: A randomized controlled trial. Nutr Metab Cardiovasc Dis. 2013;23(9):843–9. doi:10.1016/j.numecd.2012.06.005.CrossRefPubMed

41.

Karlsen A, Retterstol L, Laake P, Paur I, Bohn SK, Sandvik L, et al. Anthocyanins inhibit nuclear factor-kappaB activation in monocytes and reduce plasma concentrations of pro-inflammatory mediators in healthy adults. J Nutr. 2007;137(8):1951–4.PubMed

42.

Liu Y, Li D, Zhang Y, Sun R, Xia M. Anthocyanin increases adiponectin secretion and protects against diabetes-related endothelial dysfunction. AJP: Endocrinol Metab. 2014;306(8):E975–E88. doi:10.1152/ajpendo.00699.2013.

43.

Bonina FP, Leotta C, Scalia G, Puglia C, Trombetta D, Tringali G, et al. Evaluation of oxidative stress in diabetic patients after supplementation with a standardised red orange extract. Diabetes Nutr Metab. 2002;15(1):14–9.PubMed

44.

Ataie-Jafari A, Hosseini S, Karimi F, Pajouhi M. Effects of sour cherry juice on blood glucose and some cardiovascular risk factors improvements in diabetic women: A pilot study. Nutrition & Food Science. 2008;38(4):355–60.CrossRef

45.

Basu A, Wilkinson M, Penugonda K, Simmons B, Betts NM, Lyons TJ. Freeze-dried strawberry powder improves lipid profile and lipid peroxidation in women with metabolic syndrome: Baseline and post intervention effects. Nutr J. 2009;8:43. doi:10.1186/1475-2891-8-43.CrossRefPubMedCentralPubMed

46.

Basu A, Du M, Leyva MJ, Sanchez K, Betts NM, Wu M, et al. Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome. J Nutr. 2010;140(9):1582–7. doi:10.3945/jn.110.124701.CrossRefPubMedCentralPubMed

47.

Wright OR, Netzel GA, Sakzewski AR. A randomized, double-blind, placebo-controlled trial of the effect of dried purple carrot on body mass, lipids, blood pressure, body composition, and inflammatory markers in overweight and obese adults: The QUENCH trial. Can J Physiol Pharmacol. 2013;91(6):480–8. doi:10.1139/cjpp-2012-0349.CrossRefPubMed

48.

Kolehmainen M, Mykkanen O, Kirjavainen PV, Leppanen T, Moilanen E, Adriaens M, et al. Bilberries reduce low-grade inflammation in individuals with features of metabolic syndrome. Mol Nutr Food Res. 2012;56(10):1501–10. doi:10.1002/mnfr.201200195.CrossRefPubMed

49.

Riso P, Klimis-Zacas D, Del Bo C, Martini D, Campolo J, Vendrame S, et al. Effect of a wild blueberry (Vaccinium angustifolium) drink intervention on markers of oxidative stress, inflammation and endothelial function in humans with cardiovascular risk factors. Eur J Nutr. 2012. doi:10.1007/s00394-012-0402-9.PubMed

50.

Guo H, Zhong R, Liu Y, Jiang X, Tang X, Li Z, et al. Effects of bayberry juice on inflammatory and apoptotic markers in young adults with features of non-alcoholic fatty liver disease. Nutrition. 2014;30(2):198–203. doi:10.1016/j.nut.2013.07.023.CrossRefPubMed

51.

Kianbakht S, Abasi B, Hashem DF. Improved lipid profile in hyperlipidemic patients taking Vaccinium arctostaphylos fruit hydroalcoholic extract: A randomized double-blind placebo-controlled clinical trial. Phytother Res. 2013. doi:10.1002/ptr.5011.

52.

Tsuda T, Horio F, Uchida K, Aoki H, Osawa T. Dietary cyanidin 3-O-beta-D-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice. J Nutr. 2003;133(7):2125–30.PubMed

53.

Titta L, Trinei M, Stendardo M, Berniakovich I, Petroni K, Tonelli C, et al. Blood orange juice inhibits fat accumulation in mice. Int J Obes (Lond). 2010;34(3):578–88. doi:10.1038/ijo.2009.266.CrossRef

54.

Prior RL, Wu X, Gu L, Hager TJ, Hager A, Howard LR. Whole berries versus berry anthocyanins: Interactions with dietary fat levels in the C57BL/6 J mouse model of obesity. J Agric Food Chem. 2008;56(3):647–53. doi:10.1021/jf071993o.CrossRefPubMed

55.

Wu T, Qi X, Liu Y, Guo J, Zhu R, Chen W, et al. Dietary supplementation with purified mulberry (Morus australis Poir) anthocyanins suppresses body weight gain in high-fat diet fed C57BL/6 mice. Food Chem. 2013;141(1):482–7. doi:10.1016/j.foodchem.2013.03.046.CrossRefPubMed

56.

Prior RL, Welkes SE, Rogers TR, Khanal RC, Wu X, Howard LR. Purified blueberry anthocyanins and blueberry juice alter development of obesity in mice fed an obesogenic high-fat diet. J Agric Food Chem. 2010;58(7):3970–6. doi:10.1021/jf902852d.CrossRefPubMed

57.

Wu T, Yu Z, Tang Q, Song H, Gao Z, Chen W, et al. Honeysuckle anthocyanin supplementation prevents diet-induced obesity in C57BL/6 mice. Food Funct. 2013;4(11):1654–61. doi:10.1039/c3fo60251f.CrossRefPubMed

58.

Kaume L, Gilbert WC, Brownmiller C, Howard LR, Devareddy L. Cyanidin 3-O-β-d-glucoside-rich blackberries modulate hepatic gene expression, and anti-obesity effects in ovariectomized rats. J Funct Foods. 2012;4(2):480–8. doi:10.1016/j.jff.2012.02.008.CrossRef

59.

Badshah H, Ullah I, Kim SE, Kim TH, Lee HY, Kim MO. Anthocyanins attenuate body weight gain via modulating neuropeptide Y and GABAB1 receptor in rats hypothalamus. Neuropeptides. 2013;47(5):347–53. doi:10.1016/j.npep.2013.06.001.CrossRefPubMed

60.

Matsuda M, Shimomura I. Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases. Rev Endocr Metab Disord. 2013. doi:10.1007/s11154-013-9271-7.

61.

Evans JL, Maddux BA, Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal. 2005;7(7–8):1040–52. doi:10.1089/ars.2005.7.1040.CrossRefPubMed

62.

Wang H, Cao GH, Prior RL. Oxygen radical absorbing capacity of anthocyanins. J Agric Food Chem. 1997;45(2):304–9. doi:10.1021/jf960421t.CrossRef

63.

Jing P, Zhao S, Ruan S, Sui Z, Chen L, Jiang L, et al. Quantitative studies on structure-ORAC relationships of anthocyanins from eggplant and radish using 3D-QSAR. Food Chem. 2014;145:365–71. doi:10.1016/j.foodchem.2013.08.082.CrossRefPubMed

64.

Chiang AN, Wu HL, Yeh HI, Chu CS, Lin HC, Lee WC. Antioxidant effects of black rice extract through the induction of superoxide dismutase and catalase activities. Lipids. 2006;41(8):797–803. doi:10.1007/s11745-006-5033-6.CrossRefPubMed

65.

Roy M, Sen S, Chakraborti AS. Action of pelargonidin on hyperglycemia and oxidative damage in diabetic rats: Implication for glycation-induced hemoglobin modification. Life Sci. 2008;82(21–22):1102–10. doi:10.1016/j.lfs.2008.03.011.CrossRefPubMed

66.

Zhu W, Jia Q, Wang Y, Zhang Y, Xia M. The anthocyanin cyanidin-3-O-beta-glucoside, a flavonoid, increases hepatic glutathione synthesis and protects hepatocytes against reactive oxygen species during hyperglycemia: Involvement of a cAMP-PKA-dependent signaling pathway. Free Radic Biol Med. 2012;52(2):314–27. doi:10.1016/j.freeradbiomed.2011.10.483.CrossRefPubMed

67.

Jeong JW, Lee WS, Shin SC, Kim GY, Choi BT, Choi YH. Anthocyanins downregulate lipopolysaccharide-induced inflammatory responses in BV2 microglial cells by suppressing the NF-κB and Akt/MAPKs signaling pathways. Int J Mol Sci. 2013;14(1):1502–15. doi:10.3390/ijms14011502.CrossRefPubMedCentralPubMed

68.

Zhang Y, Lian F, Zhu Y, Xia M, Wang Q, Ling W, et al. Cyanidin-3-O-beta-glucoside inhibits LPS-induced expression of inflammatory mediators through decreasing IkappaBalpha phosphorylation in THP-1 cells. Inflamm Res. 2010;59(9):723–30. doi:10.1007/s00011-010-0183-7.CrossRefPubMed

69.

Wang Q, Xia M, Liu C, Guo H, Ye Q, Hu Y, et al. Cyanidin-3-O-beta-glucoside inhibits iNOS and COX-2 expression by inducing liver X receptor alpha activation in THP-1 macrophages. Life Sci. 2008;83(5–6):176–84. doi:10.1016/j.lfs.2008.05.017.CrossRefPubMed

70.

Speciale A, Canali R, Chirafisi J, Saija A, Virgili F, Cimino F. Cyanidin-3-O-glucoside protection against TNF-alpha-induced endothelial dysfunction: Involvement of nuclear factor-kappaB signaling. J Agric Food Chem. 2010;58(22):12048–54. doi:10.1021/jf1029515.CrossRefPubMed

71.

DeFuria J, Bennett G, Strissel KJ, Perfield 2nd JW, Milbury PE, Greenberg AS, et al. Dietary blueberry attenuates whole-body insulin resistance in high fat-fed mice by reducing adipocyte death and its inflammatory sequelae. J Nutr. 2009;139(8):1510–6. doi:10.3945/jn.109.105155.CrossRefPubMedCentralPubMed

72.

Qin B, Anderson RA. An extract of chokeberry attenuates weight gain and modulates insulin, adipogenic and inflammatory signalling pathways in epididymal adipose tissue of rats fed a fructose-rich diet. Br J Nutr. 2012;108(4):581–7. doi:10.1017/S000711451100599X.CrossRefPubMed

73.

Guo H, Xia M, Zou T, Ling W, Zhong R, Zhang W. Cyanidin 3-glucoside attenuates obesity-associated insulin resistance and hepatic steatosis in high-fat diet-fed and db/db mice via the transcription factor FoxO1. J Nutr Biochem. 2012;23(4):349–60. doi:10.1016/j.jnutbio.2010.12.013.CrossRefPubMed

74.

Hassimotto NM, Moreira V, Do Nascimento NG, Souto PC, Teixeira C, Lajolo FM. Inhibition of carrageenan-induced acute inflammation in mice by oral administration of anthocyanin mixture from wild mulberry and cyanidin-3-glucoside. Biomed Res Int. 2013;2013:146716. doi:10.1155/2013/146716.CrossRefPubMedCentralPubMed

75.

Graf D, Seifert S, Bub A, Frohling B, Dold S, Unger F, et al. Anthocyanin-rich juice does not affect gut-associated immunity in Fischer rats. Mol Nutr Food Res. 2013;57(10):1753–61. doi:10.1002/mnfr.201300022.PubMed

76.

Jayaprakasam B, Olson LK, Schutzki RE, Tai MH, Nair MG. Amelioration of obesity and glucose intolerance in high-fat-fed C57BL/6 mice by anthocyanins and ursolic acid in Cornelian cherry (Cornus mas). J Agric Food Chem. 2006;54(1):243–8. doi:10.1021/jf0520342.CrossRefPubMed

77.

Guo H, Ling W, Wang Q, Liu C, Hu Y, Xia M, et al. Effect of anthocyanin-rich extract from black rice (Oryza sativa L. indica) on hyperlipidemia and insulin resistance in fructose-fed rats. Plant Foods Hum Nutr. 2007;62(1):1–6. doi:10.1007/s11130-006-0031-7.CrossRefPubMed

78.

Sasaki R, Nishimura N, Hoshino H, Isa Y, Kadowaki M, Ichi T, et al. Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice. Biochem Pharmacol. 2007;74(11):1619–27. doi:10.1016/j.bcp.2007.08.008.CrossRefPubMed

79.

Nizamutdinova IT, Jin YC, Chung JI, Shin SC, Lee SJ, Seo HG, et al. The anti-diabetic effect of anthocyanins in streptozotocin-induced diabetic rats through glucose transporter 4 regulation and prevention of insulin resistance and pancreatic apoptosis. Mol Nutr Food Res. 2009;53(11):1419–29. doi:10.1002/mnfr.200800526.CrossRefPubMed

80.

Kurimoto Y, Shibayama Y, Inoue S, Soga M, Takikawa M, Ito C, et al. Black soybean seed coat extract ameliorates hyperglycemia and insulin sensitivity via the activation of AMP-activated protein kinase in diabetic mice. J Agric Food Chem. 2013;61(23):5558–64. doi:10.1021/jf401190y.CrossRefPubMed

81.

Guo H, Ling W, Wang Q, Liu C, Hu Y, Xia M. Cyanidin 3-glucoside protects 3 T3-L1 adipocytes against H₂O₂- or TNF-alpha-induced insulin resistance by inhibiting c-Jun NH2-terminal kinase activation. Biochem Pharmacol. 2008;75(6):1393–401. doi:10.1016/j.bcp.2007.11.016.CrossRefPubMed

82.

Tsuda T, Ueno Y, Aoki H, Koda T, Horio F, Takahashi N, et al. Anthocyanin enhances adipocytokine secretion and adipocyte-specific gene expression in isolated rat adipocytes. Biochem Biophys Res Commun. 2004;316(1):149–57.CrossRefPubMed

83.

Tsuda T, Ueno Y, Yoshikawa T, Kojo H, Osawa T. Microarray profiling of gene expression in human adipocytes in response to anthocyanins. Biochem Pharmacol. 2006;71(8):1184–97. doi:10.1016/j.bcp.2005.12.042.CrossRefPubMed

84.

Floyd ZE, Stephens JM. Controlling a master switch of adipocyte development and insulin sensitivity: Covalent modifications of PPARgamma. Biochim Biophys Acta. 2012;1822(7):1090–5. doi:10.1016/j.bbadis.2012.03.014.CrossRefPubMedCentralPubMed

85.

Scazzocchio B, Vari R, Filesi C, D’Archivio M, Santangelo C, Giovannini C, et al. Cyanidin-3-O-beta-glucoside and protocatechuic acid exert insulin-like effects by upregulating PPARgamma activity in human omental adipocytes. Diabetes. 2011;60(9):2234–44. doi:10.2337/db10-1461.CrossRefPubMedCentralPubMed

86.

Jia Y, Kim JY, Jun HJ, Kim SJ, Lee JH, Hoang MH, et al. Cyanidin is an agonistic ligand for peroxisome proliferator-activated receptor-alpha reducing hepatic lipid. Biochim Biophys Acta. 2013;1831(4):698–708. doi:10.1016/j.bbalip.2012.11.012.CrossRefPubMed

87.

Ruderman NB, Carling D, Prentki M, Cacicedo JM. AMPK, insulin resistance, and the metabolic syndrome. J Clin Invest. 2013;123(7):2764–72. doi:10.1172/JCI67227.CrossRefPubMedCentralPubMed

88.

Wei X, Wang D, Yang Y, Xia M, Li D, Li G, et al. Cyanidin-3-O-beta-glucoside improves obesity and triglyceride metabolism in KK-Ay mice by regulating lipoprotein lipase activity. J Sci Food Agric. 2011;91(6):1006–13. doi:10.1002/jsfa.4275.CrossRefPubMed

89.

Zhang Y, Wang X, Wang Y, Liu Y, Xia M. Supplementation of cyanidin-3-O-beta-glucoside promotes endothelial repair and prevents enhanced atherogenesis in diabetic apolipoprotein E-deficient mice. J Nutr. 2013;143(8):1248–53. doi:10.3945/jn.113.177451.CrossRefPubMed

90.

Guo H, Guo J, Jiang X, Li Z, Ling W. Cyanidin-3-O-beta-glucoside, a typical anthocyanin, exhibits antilipolytic effects in 3 T3-L1 adipocytes during hyperglycemia: Involvement of FoxO1-mediated transcription of adipose triglyceride lipase. Food Chem Toxicol. 2012;50(9):3040–7. doi:10.1016/j.fct.2012.06.015.CrossRefPubMed

91.

Hwang YP, Choi JH, Han EH, Kim HG, Wee JH, Jung KO, et al. Purple sweet potato anthocyanins attenuate hepatic lipid accumulation through activating adenosine monophosphate-activated protein kinase in human HepG2 cells and obese mice. Nutr Res. 2011;31(12):896–906. doi:10.1016/j.nutres.2011.09.026.CrossRefPubMed

92.

Guo H, Liu G, Zhong R, Wang Y, Wang D, Xia M. Cyanidin-3-O-beta-glucoside regulates fatty acid metabolism via an AMP-activated protein kinase-dependent signaling pathway in human HepG2 cells. Lipids Health Dis. 2012;11:10. doi:10.1186/1476-511X-11-10.CrossRefPubMedCentralPubMed

93.

Kang MK, Li J, Kim JL, Gong JH, Kwak SN, Park JH, et al. Purple corn anthocyanins inhibit diabetes-associated glomerular monocyte activation and macrophage infiltration. Am J Physiol Renal Physiol. 2012;303(7):F1060–9. doi:10.1152/ajprenal.00106.2012.CrossRefPubMed

94.

Li J, Lim SS, Lee JY, Kim JK, Kang SW, Kim JL, et al. Purple corn anthocyanins dampened high-glucose-induced mesangial fibrosis and inflammation: Possible renoprotective role in diabetic nephropathy. J Nutr Biochem. 2012;23(4):320–31. doi:10.1016/j.jnutbio.2010.12.008.CrossRefPubMed

95.

Nabae K, Hayashi SM, Kawabe M, Ichihara T, Hagiwara A, Tamano S, et al. A 90-day oral toxicity study of purple corn color, a natural food colorant, in F344 rats. Food Chem Toxicol. 2008;46(2):774–80. doi:10.1016/j.fct.2007.10.004.CrossRefPubMed

96.

Hassellund SS, Flaa A, Sandvik L, Kjeldsen SE, Rostrup M. Effects of anthocyanins on blood pressure and stress reactivity: A double-blind randomized placebo-controlled crossover study. J Hum Hypertens. 2012;26(6):396–404. doi:10.1038/jhh.2011.41.CrossRefPubMed

97.

Ohguro H, Ohguro I, Katai M, Tanaka S. Two-year randomized, placebo-controlled study of black currant anthocyanins on visual field in glaucoma. Ophthalmologica. 2012;228(1):26–35. doi:10.1159/000335961.CrossRefPubMed

Title: The update of anthocyanins on obesity and type 2 diabetes: Experimental evidence and clinical perspectives
Authors: Honghui Guo
Wenhua Ling
Publication date: 01-03-2015
Publisher: Springer US
Published in: Reviews in Endocrine and Metabolic Disorders / Issue 1/2015
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI: https://doi.org/10.1007/s11154-014-9302-z

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2015

The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity

Inflammation in sleep apnea: An update

Regulation of energy balance by inflammation: Common theme in physiology and pathology

Pleiotropic actions of iron balance in diabetes mellitus

Angiogenesis in diabetes and obesity

The role of the Nrf2/Keap1 pathway in obesity and metabolic syndrome

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage